Jefferies Maintains Sell Rating on Palantir, Citing Overvaluation and Insider Selling

GuruFocus.com
03-19

Jefferies analyst Brent Thill reaffirmed a Sell rating on Palantir Technologies (PLTR, Financials), maintaining a $60 price target, citing concerns about valuation and insider selling.

  • Warning! GuruFocus has detected 2 Warning Sign with BDRBF.

Despite Palantir's advancement in artificial intelligence, Thill said it is the most costly company Jefferies covers. The company thinks there is little upward potential for investors as the stock price already accounts for momentum connected to artificial intelligence.Insider selling was one of the main issues the paper highlighted. Recent sales of $310 million worth of Palantir shares by co-founder Stephen Cohen indicate overvaluation or management's misgivings about the company's future stock performance, according to Jefferies. Although insider sales do not always point to basic flaws, big transactions of this kind might cause investor questions about leadership credibility.Jefferies noted Palantir's artificial intelligence developments despite these misgivings. Attending the company's latest AI Platform event, Palantir showed case studies proving the platform's capacity to improve operational efficiency. Designed to enable companies to include artificial intelligence into regular operations, the AI tools were said to be interesting. But Jefferies thinks Palantir's stock price already shows these qualities.Growing investor excitement in artificial intelligence has helped Palantir gain from which its stock has surged recently. Instinctive in AI-driven data analytics and government contracts, the business has drawn attention from institutional and individual investors. Jefferies is still dubious about the value of the company, however, as it trades at a premium above rivals in the software and artificial intelligence industries.

This article first appeared on GuruFocus.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10